Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Advanced MRI may detect prostate cancer progression: New study

An advanced type of magnetic resonance imaging (MRI) could be used instead of invasive biopsy to determine whether the cancer patients under Active Surveillance require treatment, according to a new study.

For the study, scientists at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital used diffusion-weighted MRI to scan 50 patients who were at their initial prostate cancer diagnosis.

The scientists conducted a follow-up appointment at an average of two years later, and after each scan, they calculated a figure called an Apparent Diffusion Coefficient – a measurement of water movement within tissue.

By the follow-up appointment, 17 men required treatment as their cancer had progressed, while 33 men remained under Active Surveillance.

The scientists found that for men who progressed to treatment, the diffusion-weighted measurements fell between the two scans, while the measurements remained similar for men under Active Surveillance.

Study leader professor Nandita deSouza said diffusion-weighted MRI has a lot of potential for monitoring patients under Active Surveillance, as the scans clearly showed which men’s cancers were progressing.

"If the technique continues to show promise in larger-scale studies, it could one day save men under Active Surveillance from the discomfort and potential complications of regular biopsies," deSouza said.